92 related articles for article (PubMed ID: 2535935)
1. Effects of nitroprusside and nitroglycerin on cGMP content and PGI2 formation in aorta and vena cava.
Tsai SC; Adamik R; Manganiello VC; Moss J
Biochem Pharmacol; 1989 Jan; 38(1):61-5. PubMed ID: 2535935
[TBL] [Abstract][Full Text] [Related]
2. Vascular smooth muscle relaxation by nitro compounds: reduced relaxation and cGMP elevation in tolerant vessels and reversal of tolerance by dithiothreitol.
Axelsson KL; Andersson RG; Wikberg JE
Acta Pharmacol Toxicol (Copenh); 1982 May; 50(5):350-7. PubMed ID: 6287805
[TBL] [Abstract][Full Text] [Related]
3. Effects of nitroprusside, glyceryl trinitrate, and 8-bromo cyclic GMP on phosphorylase a formation and myosin light chain phosphorylation in rat aorta.
Johnson RM; Lincoln TM
Mol Pharmacol; 1985 Mar; 27(3):333-42. PubMed ID: 2983183
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the effects of forskolin and nitroprusside on cyclic nucleotides and relaxation in the rat aorta.
Lincoln TM; Fisher-Simpson V
Eur J Pharmacol; 1984 May; 101(1-2):17-27. PubMed ID: 6086362
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of nitroglycerin and nitroprusside on prostacyclin generation in adult human vessel wall.
Mehta J; Mehta P; Roberts A; Faro R; Ostrowski N; Brigmon L
J Am Coll Cardiol; 1983 Oct; 2(4):625-30. PubMed ID: 6411788
[TBL] [Abstract][Full Text] [Related]
6. Effects of nitroprusside on the bradykinin responsiveness of human fibroblasts.
Tsai SC; Adamik R; Hom BE; Manganiello VC; Moss J
Mol Pharmacol; 1986 Sep; 30(3):274-8. PubMed ID: 3018483
[TBL] [Abstract][Full Text] [Related]
7. Vascular tolerance to nitroglycerin and cyclic GMP generation in rat aortic smooth muscle.
Keith RA; Burkman AM; Sokoloski TD; Fertel RH
J Pharmacol Exp Ther; 1982 Jun; 221(3):525-31. PubMed ID: 6283056
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine.
Katsuki S; Arnold W; Mittal C; Murad F
J Cyclic Nucleotide Res; 1977 Feb; 3(1):23-35. PubMed ID: 14978
[TBL] [Abstract][Full Text] [Related]
9. Effects of sodium nitroprusside, nitroglycerin, and sodium azide on levels of cyclic nucleotides and mechanical activity of various tissues.
Katsuki S; Arnold WP; Murad F
J Cyclic Nucleotide Res; 1977 Aug; 3(4):239-47. PubMed ID: 199626
[TBL] [Abstract][Full Text] [Related]
10. Activation of guanosine 3',5'-cyclic monophosphate (cGMP)-dependent protein kinase in rabbit aorta by nitroglycerin and sodium nitroprusside.
Patel AI; Diamond J
J Pharmacol Exp Ther; 1997 Nov; 283(2):885-93. PubMed ID: 9353410
[TBL] [Abstract][Full Text] [Related]
11. Reduction of 14C-norepinephrine metabolism in rabbit aorta by vasodilators.
Williams PB; Hudgins PM
Blood Vessels; 1976; 13(1-2):48-57. PubMed ID: 813796
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo interactions of nitrovasodilators and zaprinast, a cGMP-selective phosphodiesterase inhibitor.
Merkel LA; Rivera LM; Perrone MH; Lappe RW
Eur J Pharmacol; 1992 May; 216(1):29-35. PubMed ID: 1326438
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary vascular smooth muscle relaxation by cGMP- versus cAMP-mediated mechanisms.
Fullerton DA; Hahn AR; Banerjee A; Harken AH
J Surg Res; 1994 Aug; 57(2):259-63. PubMed ID: 7913147
[TBL] [Abstract][Full Text] [Related]
14. Specificity of different organic nitrates to elicit NO formation in rabbit vascular tissues and organs in vivo.
Mülsch A; Bara A; Mordvintcev P; Vanin A; Busse R
Br J Pharmacol; 1995 Nov; 116(6):2743-9. PubMed ID: 8590999
[TBL] [Abstract][Full Text] [Related]
15. Sodium nitroprusside inhibits lactate formation in rat atria: is cyclic GMP involved?
Laustiola K; Vuorinen P; Vapaatalo H; Metsä-Ketelä T
Acta Pharmacol Toxicol (Copenh); 1983 Mar; 52(3):195-200. PubMed ID: 6303048
[TBL] [Abstract][Full Text] [Related]
16. [Mechanisms of NO-dependent relaxation in smooth muscles of the rat aorta with nitro compounds].
Kovalev IV; Popov AG; Panov AA; Borodin IuL; Afinogenova IaD; Kapilevich LV; Baskakov MB; Medvedev MA
Eksp Klin Farmakol; 2001; 64(3):33-6. PubMed ID: 11558436
[TBL] [Abstract][Full Text] [Related]
17. Clinical tolerance to nitroglycerin is due to impaired biotransformation of nitroglycerin and biological counterregulation, not to desensitization of guanylate cyclase.
Mülsch A; Busse R; Bassenge E
Z Kardiol; 1989; 78 Suppl 2():22-5; discussion 64-7. PubMed ID: 2573982
[TBL] [Abstract][Full Text] [Related]
18. Alteration of cyclic GMP metabolism by CD-349, a novel calcium antagonist, and by sodium nitroprusside in bovine intrapulmonary artery and vein.
Tanaka M; Muramatsu M; Aihara H
Biochem Pharmacol; 1989 Jun; 38(12):1985-91. PubMed ID: 2545208
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of nitroprusside and nitroglycerin; actions on phasic and tonic components of arterial smooth muscle contraction.
Watkins RW; Davidson IW
Eur J Pharmacol; 1980 Mar; 62(2-3):191-200. PubMed ID: 6769682
[No Abstract] [Full Text] [Related]
20. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
